TIMEPLAN KURS ANALYSE AV REGISTERDATA I FORSKNING Mandag 31. mars Kl Tittel Foredragsholder 1000-1025 Registrering og kaffe 1025-1030 Velkommen 1030-1115 Crashkurs i epidemiologi Bjarne Koster Jacobsen 1130-1215 Crashkurs i statistikk Lena Ringstad Olsen Alexander Walnum 1215-1300 Lunsj 1300-1345 Registerdata vs. RCT Foreleser forespurt 1400-1445 Multippel testing Ellinor Ytterstad Pause med kake/frukt 1500-1545 Sentrale registre styrker, svakheter, koblingsmuligheter Martha Ebbing forespurt, evt en annen fra ett av de store registrene 1600-1645 Sentrale registre styrker, svakheter, koblingsmuligheter Martha Ebbing forespurt, evt en annen fra ett av de store registrene Tirsdag 1. april 0830-0915 Time 1. Innføring i DAGs, kasualitet og kausal inferens i forbindelse med det 0930-1015 Time 2. Innføring i DAGs, kasualitet og kausal inferens i forbindelse med det 1030-1115 Time 3. Innføring i DAGs, kasualitet og kausal inferens i forbindelse med det Odd O Aalen Odd O Aalen Odd O Aalen 1113-1200 Lunsj 1200-1245 Nationella diabetesregisteret Erfaringer fra et nasjonalt register under utvikling 1300-1345 Nationella diabetesregisteret Erfaringer fra et nasjonalt register under utvikling Soffía Guðbjörnsdóttir forespurt Soffía Guðbjörnsdóttir forespurt Pause med kake/frukt

1400-1445 Propensity score Trond Moger forespurt 1500-1545 Stratifisering og justering Trond Moger forespurt Onsdag 2. april 0830-0915 Swedeheart registry Eksempler på registerdata brukt i forskning 0930-1015 Swedeheart registry Eksempler på registerdata brukt i forskning Stefan James forespurt Stefan James forespurt 1030-1115 Juridisk regulering av helseregistre Heidi Talsethagen 1115-1200 Lunsj 1200-1245 Publisering av effektevaluering Mette Kalager basert på registerdata 1300-1345 PROM pasientrapporterte utfall Foreleser fra SKDE Pause med kake/frukt 1400-1445 PROM pasientrapporterte utfall Foreleser fra SKDE 1500-1545 Taffelforelesning: Fornuftig bruk av registerdata Olav Helge Førde forespurt 1600-1630 Informasjon om eksamen

LITTERATURLISTE Senter for klinisk dokumentasjon og evaluering: Håndbok for medisinske kvalitetsregistre. Tromsø: SKDE, 2012. http://www.helsenord.no/getfile.php/skde/dokumenter/handbok_120411_siste.pdf (31 sider) Cole SR, Hernàn MA (2002). Fallibility in estimating direct effects. International Journal of Epidemiology; 31:163-165 (3 sider) Greenland S, Pearl J, Robins JM (1999). Causal Diagrams for Epidemiologic Research. Epidemiology 10:37-48 (13 sider) Miguel A. Hernán, Sonia Hernández-Díaz, Martha M.Werler et al. (2002) Causal Knowledge as a Prerequisite for Confounding Evaluation: An Application to Birth Defects Epidemiology. American Journal of Epidemiology 155: 176-184. (9 sider) Theis Lange, Jørgen V. Hansen (2011). Direct and Indirect Effects in a Survival Context. Epidemiology 22: 575-581 (7 sider) Currie CJ, Poole CD, Gale EA (2009). The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 52:1766-77. (11 sider) Jonasson JM, Ljung R, Talback M, Haglund B, Gudbjornsdottir S, Steineck G (2009). Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden. Diabetologia 52:1745-54. (10 sider) Ralph B D Agostino jr.(1998) Tutorial in biostatics propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Statistics in Medicine 17:2265-2281 (17 sider) Ole Fröbert, Bo Lagerqvist, Thórarinn Gudnason et al. (2010). Thrombus Aspiration in ST- Elevation myocardial infarction in Scandinavia (TASTE trial). A multicenter, prospective, randomized, controlled clinical registry trial based on the Swedish angiography and angioplasty registry (SCAAR) platform. Study design and rationale. American Heart Journal 160: 1042-1048 (7 sider) Ole Fröbert, Bo Lagerqvist, Martin Kreutzer, et al. (2010) Thrombus aspiration in STelevation myocardial infarction in Sweden. A short report on real world outcome. American Heart Journal 160: 1042-1048 (2 sider) Tone Svilaas, Pieter J. Vlaar, Iwan C. van der Horst et al. (2008)Thrombus Aspiration during Primary Percutaneous Coronary Intervention. The New England Journal of Medicine 358: 557-567 (11 sider) Pieter J Vlaar, Tone Svilaas, Iwan C van der Horst et al. (2008). Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study. Lancet 371: 1915-1920 (6 sider)

Storey JD (2010). False discovery rates. In: International Encyclopedia of Statistical Science, Lovric M (editor). (7 sider) Storey JD and Tibshirani R (2003). Statistical significance for genome-wide studies. Proceedings of the National Academy of Sciences, 100: 9440-9445. (6 sider) Gerstman B. Stratified Analysis: Introduction to Confounding and Interaction. StatPrimer (Version 6.4) (13 sider). Kalager M, Zelen M, Langmark F, Adami HO (2010). Effect of screening mammography on breast-cancer mortality in Norway. New England Journal of Medicine 363: 1203-10 (8 sider). Mamdani M, Sykora K, Li P, Normand SL, Streiner DL, Austin PC, et al. Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. BMJ 2005 Apr 23;330(7497):960-2. (3 sider) von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP (2008) STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 61:344-9. (6 sider)